Approaches of integrating the development of guidelines and quality indicators: a systematic review.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
16 Sep 2020
Historique:
received: 23 04 2020
accepted: 17 08 2020
entrez: 17 9 2020
pubmed: 18 9 2020
medline: 26 1 2021
Statut: epublish

Résumé

Guidelines and quality indicators (for example as part of a quality assurance scheme) aim to improve health care delivery and health outcomes. Ideally, the development of quality indicators should be grounded in evidence-based, trustworthy guideline recommendations. However, anecdotally, guidelines and quality assurance schemes are developed independently, by different groups of experts who employ different methodologies. We conducted an extension and update of a previous systematic review to identify, describe and evaluate approaches to the integrated development of guidelines and related quality indicators. On May 24th, 2019 we searched in Medline, Embase and CINAHL and included studies if they reported a methodological approach to guideline-based quality indicator development and were published in English, French, or German. Out of 16,034 identified records, we included 17 articles that described a method to integrate guideline recommendations development and quality indicator development. Added to the 13 method articles from original systematic review we included a total 30 method articles. We did not find any evaluation studies. In most approaches, guidelines were a source of evidence to inform the quality indicator development. The criteria to select recommendations (e.g. level of evidence or strength of the recommendation) and to generate, select and assess quality indicators varied widely. We found methodological approaches that linked guidelines and quality indicator development explicitly, however none of the articles reported a conceptual framework that fully integrated quality indicator development into the guideline process or where quality indicator development was part of the question formulation for developing the guideline recommendations. In our systematic review we found approaches which explicitly linked guidelines with quality indicator development, nevertheless none of the articles reported a comprehensive and well-defined conceptual framework which integrated quality indicator development fully into the guideline development process.

Sections du résumé

BACKGROUND BACKGROUND
Guidelines and quality indicators (for example as part of a quality assurance scheme) aim to improve health care delivery and health outcomes. Ideally, the development of quality indicators should be grounded in evidence-based, trustworthy guideline recommendations. However, anecdotally, guidelines and quality assurance schemes are developed independently, by different groups of experts who employ different methodologies. We conducted an extension and update of a previous systematic review to identify, describe and evaluate approaches to the integrated development of guidelines and related quality indicators.
METHODS METHODS
On May 24th, 2019 we searched in Medline, Embase and CINAHL and included studies if they reported a methodological approach to guideline-based quality indicator development and were published in English, French, or German.
RESULTS RESULTS
Out of 16,034 identified records, we included 17 articles that described a method to integrate guideline recommendations development and quality indicator development. Added to the 13 method articles from original systematic review we included a total 30 method articles. We did not find any evaluation studies. In most approaches, guidelines were a source of evidence to inform the quality indicator development. The criteria to select recommendations (e.g. level of evidence or strength of the recommendation) and to generate, select and assess quality indicators varied widely. We found methodological approaches that linked guidelines and quality indicator development explicitly, however none of the articles reported a conceptual framework that fully integrated quality indicator development into the guideline process or where quality indicator development was part of the question formulation for developing the guideline recommendations.
CONCLUSIONS CONCLUSIONS
In our systematic review we found approaches which explicitly linked guidelines with quality indicator development, nevertheless none of the articles reported a comprehensive and well-defined conceptual framework which integrated quality indicator development fully into the guideline development process.

Identifiants

pubmed: 32938461
doi: 10.1186/s12913-020-05665-w
pii: 10.1186/s12913-020-05665-w
pmc: PMC7493171
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

875

Références

Int Psychogeriatr. 2012 Jun;24(6):921-30
pubmed: 22251776
Psychiatr Q. 2005 Fall;76(3):213-30
pubmed: 16080418
Implement Sci. 2016 Jan 15;11:6
pubmed: 26772173
Pediatr Blood Cancer. 2019 Feb;66(2):e27504
pubmed: 30318786
BMJ Open. 2019 Feb 27;9(2):e023595
pubmed: 30819701
Br J Gen Pract. 2003 Sep;53(494):690-6
pubmed: 15103876
Gynecol Oncol. 2013 Dec;131(3):512-9
pubmed: 24103471
Am J Phys Med Rehabil. 2001 Mar;80(3):235-42
pubmed: 11237279
Ann Am Thorac Soc. 2014 May;11(4):S186-95
pubmed: 24828810
JAMA. 1988 Sep 23-30;260(12):1743-8
pubmed: 3045356
BMJ Qual Saf. 2016 Jul;25(7):525-34
pubmed: 26384710
Z Evid Fortbild Qual Gesundhwes. 2011;105(1):27-37
pubmed: 21382602
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
BMJ. 1995 Aug 5;311(7001):370-3
pubmed: 7640546
Qual Prim Care. 2012;20(1):47-55
pubmed: 22584367
Hum Reprod. 2016 Jun;31(6):1208-18
pubmed: 27112700
Hypertens Pregnancy. 2013;32(1):20-31
pubmed: 22958211
Neurology. 2010 Nov 30;75(22):2021-7
pubmed: 21115958
Neth J Med. 2007 Jan;65(1):15-22
pubmed: 17293635
AMIA Annu Symp Proc. 2003;:11-5
pubmed: 14728124
BMC Fam Pract. 2015 Oct 28;16:156
pubmed: 26507739
Qual Lett Healthc Lead. 1995 Oct;7(8):21-3
pubmed: 10152734
J Psychiatr Pract. 2008 May;14 Suppl 2:18-30
pubmed: 18677196
J Am Coll Cardiol. 2002 Dec 4;40(11):1895-901
pubmed: 12475447
Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):375-88
pubmed: 19299203
Circulation. 2005 Apr 5;111(13):1703-12
pubmed: 15811870
Int Forum Allergy Rhinol. 2018 Dec;8(12):1369-1379
pubmed: 29999592
Implement Sci. 2012 Mar 21;7:21
pubmed: 22436067
Int J Evid Based Healthc. 2019 Jan 9;:
pubmed: 30633009
J Head Trauma Rehabil. 2018 Sep/Oct;33(5):296-305
pubmed: 30188459
Chest. 2014 Sep;146(3):659-669
pubmed: 24700172
BMJ. 2019 Jul 19;366:l4606
pubmed: 31324659
Qual Prim Care. 2011;19(3):155-66
pubmed: 21781431
J Am Coll Cardiol. 2010 Nov 16;56(21):1767-82
pubmed: 21070935

Auteurs

Miranda W Langendam (MW)

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health institute, Amsterdam, Netherlands.

Thomas Piggott (T)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.

Monika Nothacker (M)

Institute of Medical Knowledge Management, Association of the Scientific Medical Societies, Berlin, Germany.

Arnav Agarwal (A)

Department of Medicine, University of Toronto, Toronto, ON, Canada.

David Armstrong (D)

Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Canada.

Tejan Baldeh (T)

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health institute, Amsterdam, Netherlands.

Jeffrey Braithwaite (J)

Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Rd, Sydney, Australia.

Carolina Castro Martins (C)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Department of Pediatric Dentistry, Dental School, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Andrea Darzi (A)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.

Itziar Etxeandia (I)

IKOetxe - Ikerkuntza Osaungintza, Health Research, Gipuzkoa, Irun, Basque Country, Spain.

Ivan Florez (I)

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health institute, Amsterdam, Netherlands.
Department of Pediatrics, University of Antioquia, Medellin, Colombia.

Jan Hoving (J)

Coronel Institute of Occupational Health and Research Center for Insurance Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

Samer G Karam (SG)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.

Thomas Kötter (T)

Institute of Family Medicine, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Reem A Mustafa (RA)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Department of Internal Medicine, University of Kansas Medical Center, Kansas, USA.

Giovanna E U Muti-Schünemann (GEU)

Department of Systemic Pathology, Vita Salute San Raffaele University, Milan, Italy.

Philip J van der Wees (PJ)

Department of Rehabilitation and IQ healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.

Markus Follmann (M)

German Cancer Society, Freiburg, Germany.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. schuneh@mcmaster.ca.
Department of Medicine, Hamilton, McMaster University, Hamilton, Canada. schuneh@mcmaster.ca.
Department of Health Research Methods, Evidence and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada. schuneh@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH